Stocktoria

REGENERON PHARMACEUTICALS, INC. REGN

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1991-04-02 · LEI

REGENERON PHARMACEUTICALS, INC. statistics & valuation

Market cap$66.4B
P / E14.7×
P / S4.6×
P / B2.1×
Dividend yield0.56%
Net margin31.4%
Return on equity14.4%
Net cash$1.1B
Net debt / EBITDA-0.3×
Enterprise value USD$65.2B
EV / EBITDA15.8×
Earnings yield EBIT/EV5.5%
Return on capital9.9%
Graham number -35.1%$518.29

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($518.29); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
18.40% 20.40% 47.50% 32.30% 41.30% 50.20% 35.60% 30.10% 31.10% 31.40% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
27.40% 35.40% 49.30% 33.70% 42.10% 55.70% 38.90% 30.90% 28.10% 24.90% 2016201720182019202020212022202320242025
Return on equity (%)
20.10% 19.50% 27.90% 19.10% 31.90% 43.00% 19.10% 15.20% 15.00% 14.40% 2016201720182019202020212022202320242025
Shares outstanding
116.3M 115.9M 114.8M 114.6M 115.1M 112.2M 113.5M 113.7M 115.1M 108.6M 2016201720182019202020212022202320242025
Net debt ($)
-$1.62B -$215.2M -$905.6M -$1.12B -$747.1M -$503.8M -$1.13B 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
12.80% 13.70% 20.80% 14.30% 20.50% 31.70% 14.90% 12.00% 11.70% 11.10% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
0.00× 0.18× 0.11× 0.09× 0.08× 0.07× 0.06× 2016201720182019202020212022202320242025
EPS ($)
$7.70 $10.34 $21.29 $18.46 $30.52 $71.97 $38.22 $34.77 $38.34 $41.48 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

REGENERON PHARMACEUTICALS, INC. trades at about 19.2× earnings — near its 10-year norm (10-year range 8.5×–46.7×, median 19.8×).

8.5× 46.7×

Shaded band = 10-year range (8.5×–46.7×); dot = today's 19.2×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin24.9%28.1%30.9%38.9%55.7%42.1%33.7%49.3%35.4%27.4%
Net margin31.4%31.1%30.1%35.6%50.2%41.3%32.3%47.5%20.4%18.4%
Return on assets11.1%11.7%12.0%14.9%31.7%20.5%14.3%20.8%13.7%12.8%
Return on equity14.4%15.0%15.2%19.1%43.0%31.9%19.1%27.9%19.5%20.1%
Debt / equity0.06×0.07×0.08×0.09×0.11×0.18×0.00×———
Current ratio4.134.735.695.063.563.633.674.473.822.56

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.